C07D 251/10
Having two double bonds between ring members or between ring members and
Official title: having two double bonds between ring members or between ring members and non-ring members
C07D251/10 (Having two double bonds between ring members or between ring members and) appears on 61 US grants and 61 published applications in this corpus.
Search patents in C07D- Granted patents
- 61
- Published applications
- 61
- Assignees
- 34
- Inventors
- 140
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 1 |
| 2003 | 1 | 3 |
| 2004 | 0 | 3 |
| 2005 | 3 | 3 |
| 2006 | 2 | 3 |
| 2007 | 1 | 1 |
| 2008 | 1 | 4 |
| 2009 | 4 | 1 |
| 2010 | 1 | 0 |
| 2011 | 0 | 5 |
| 2012 | 1 | 2 |
| 2013 | 1 | 5 |
| 2014 | 5 | 3 |
| 2015 | 3 | 2 |
| 2016 | 3 | 2 |
| 2017 | 5 | 5 |
| 2018 | 4 | 4 |
| 2019 | 0 | 2 |
| 2020 | 4 | 2 |
| 2021 | 3 | 1 |
| 2022 | 0 | 1 |
| 2023 | 2 | 2 |
| 2024 | 1 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cyano-pyrimidine inhibitors of EGFR/HER24 Aug 2026US 12,698,261 B2Dana-Farber Cancer Institute, Inc.
- Compound and an organic semiconducting layer, an organic electronic device, a display device and a lighting device comprising the same2 Dec 2025US 12,486,247 B2Novaled GmbH
- Hydantoin containing deoxyuridine triphosphatase inhibitors24 Sep 2024US 12,098,133 B2CV6 Therapeutics (NI) Limited
- Compound having isocyanuric skeleton and composition in which said compound is included25 Apr 2023US 11,634,608 B2Daikin Industries, Ltd.
- Hydantoin containing deoxyuridine triphosphatase inhibitors21 Feb 2023US 11,584,723 B2CV6 Therapeutics (NI) Limited
- Compound and an organic semiconducting layer, an organic electronic device, a display device and a lighting device comprising the same12 Mar 2026US 2026/0070883 A1Novaled GmbH
- Process For Preparation of Imeglimin and Salts Thereof13 Nov 2025US 2025/0346566 A1Harman Finochem Limited
- Hydantoin containing deoxyuridine triphosphatase inhibitors12 Jun 2025US 2025/0188039 A1CV6 Therapeutics (NI) Limited
- Cleavable linker-containing ionizable lipids and lipid carriers for therapeutic compositions5 Sep 2024US 2024/0293318 A1Flagship Pioneering Innovations Vii, LLC
- Compound and an organic semiconducting layer, an organic electronic device, a display device and a lighting device comprising the same25 Apr 2024US 2024/0132468 A1Novaled GmbH
Most cited
By later US patents
- 3-Amino-5-substituted-6-halo-N-(4,4-disubs tituted-6-substituted-1,3,5-triazin-2-yl)-2-pyrazinecarboxamides23US 4,272,537 AMerck & Co., Inc. · 1981
- Biguanide compositions and methods of treating metabolic disorders23US 8,796,338 B2Elcelyx Therapeutics, Inc. · 2014
- Biphenyl-substituted triazines22US 6,255,483 B1Ciba Specialty Chemicals Corporation · 2001
- Compositions and methods of treating metabolic disorders21US 9,211,263 B2Elcelyx Therapeutics, Inc. · 2015
- Process for the preparation of hydroxyphenyl-1,3,5-triazines19US 5,478,935 ACiba-Geigy Corporation · 1995